I'm sorry, Ben; that was just a PR exercise. The reality is that Moderna and all mRNA manufacturers understand that in the mRNA space, there's actually very little IP. It's a trade secret.
You can share your IP. You can share the sequence of your mRNA, but it's a trade secret with regard to how you optimized it, what codons you used and what your purification process is. Moderna's not going to share that. They'll share their IP, but nobody will know what to do with it. The reason they took that stance was so they could sound like they're above the fray while they are trampling on a Canadian company's IP for the delivery. It was a strategic move.